U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07176663) titled 'Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure' on Sept. 05.
Brief Summary: Diabetes management presents a complex clinical scenario marked by several challenges, especially in chronic kidney failure. These include navigating potential drug interactions between oral antidiabetic therapies and other agents. Furthermore, these patients may experience various adverse drug effects, such as lactic acidosis, electrolyte abnormalities such as hypomagnesemia, fluid retention, and lipid derangements, which can further augment overall morbidity. Consequently, many patients receive insulin. However, prolonged intensiv...